造血干细胞移植综述

Q3 Medicine

Tokai Journal of Experimental and Clinical Medicine Pub Date : 2023-03-18 DOI:10.52142/omujecm.40.1.27

Neslihan Meriç

{"title":"造血干细胞移植综述","authors":"Neslihan Meriç","doi":"10.52142/omujecm.40.1.27","DOIUrl":null,"url":null,"abstract":"Hematopoietic stem cell transplantation (HSCT) is the intravenous administration of hematopoietic stem cells (HSC) to restore blood cell production in individuals whose bone marrow or immune system is damaged or dysfunctional. This approach has been utilized to treat a variety of malignant and nonmalignant disorders for the past half-century. HSCT is performed in two ways, autologous and allogeneic. In the clinic, the type of stem cell transplant is decided for the patient according to the patient's diagnosis. Both types of transplantation have advantages as well as disadvantages. Knowing and managing the HSCT process well affects the success of the transplant. Knowing the complications that may occur after transplantation will facilitate the treatment process of the patient. In this short review, the HSCT process has been tried to be explained with general titles.","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Overview of hematopoietic stem cell transplantation\",\"authors\":\"Neslihan Meriç\",\"doi\":\"10.52142/omujecm.40.1.27\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hematopoietic stem cell transplantation (HSCT) is the intravenous administration of hematopoietic stem cells (HSC) to restore blood cell production in individuals whose bone marrow or immune system is damaged or dysfunctional. This approach has been utilized to treat a variety of malignant and nonmalignant disorders for the past half-century. HSCT is performed in two ways, autologous and allogeneic. In the clinic, the type of stem cell transplant is decided for the patient according to the patient's diagnosis. Both types of transplantation have advantages as well as disadvantages. Knowing and managing the HSCT process well affects the success of the transplant. Knowing the complications that may occur after transplantation will facilitate the treatment process of the patient. In this short review, the HSCT process has been tried to be explained with general titles.\",\"PeriodicalId\":38819,\"journal\":{\"name\":\"Tokai Journal of Experimental and Clinical Medicine\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tokai Journal of Experimental and Clinical Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52142/omujecm.40.1.27\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tokai Journal of Experimental and Clinical Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52142/omujecm.40.1.27","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

造血干细胞移植(HSCT)是通过静脉注射造血干细胞(HSC)来恢复骨髓或免疫系统受损或功能失调的个体的血细胞生成。在过去的半个世纪里，这种方法被用于治疗各种恶性和非恶性疾病。移植有两种方式，自体移植和异体移植。在临床上，干细胞移植的类型是根据患者的诊断来决定的。两种类型的移植都有优点和缺点。了解和管理好造血干细胞移植过程影响移植的成功。了解移植后可能出现的并发症将有助于患者的治疗过程。在这篇简短的综述中，HSCT过程已经试图用一般的标题来解释。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Overview of hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation (HSCT) is the intravenous administration of hematopoietic stem cells (HSC) to restore blood cell production in individuals whose bone marrow or immune system is damaged or dysfunctional. This approach has been utilized to treat a variety of malignant and nonmalignant disorders for the past half-century. HSCT is performed in two ways, autologous and allogeneic. In the clinic, the type of stem cell transplant is decided for the patient according to the patient's diagnosis. Both types of transplantation have advantages as well as disadvantages. Knowing and managing the HSCT process well affects the success of the transplant. Knowing the complications that may occur after transplantation will facilitate the treatment process of the patient. In this short review, the HSCT process has been tried to be explained with general titles.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Tokai Journal of Experimental and Clinical Medicine Medicine-Medicine (all)

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： The Tokai Journal of Experimental and Clinical Medicine, also referred to as Tokai Journal, is an official quarterly publication of the Tokai Medical Association. Tokai Journal publishes original articles that deal with issues of clinical, experimental, socioeconomic, cultural and/or historical importance to medical science and related fields. Manuscripts may be submitted as full-length Original Articles or Brief Communications. Tokai Journal also publishes reviews and symposium proceedings. Articles accepted for publication in Tokai Journal cannot be reproduced elsewhere without written permission from the Tokai Medical Association. In addition, Tokai Journal will not be held responsible for the opinions of the authors expressed in the published articles.